Skip to content

Semaglutide studies: 1,194 papers with results

Page 17 of 24

  1. Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report.

    Stojkovska A · The Journal of international medical research · 2025

    Case report or series · 3 results

  2. A case report of semaglutide induced sarcopenia: causes of fatigue in older adults.

    Mohamad AA · Korean journal of family medicine · 2025

    Case report or series · 5 results

  3. Non arteritic ischemic optic neuropathy in a patient taking semaglutide: Is there a relation? A case report and a review of the literature.

    Maceroni M · European journal of ophthalmology · 2025

    Case report or series · 1 result

  4. Idiopathic and Metabolic Triggers Leading to Recurrent Acute Pancreatitis in a 30-Year-Old Woman.

    Ahmed F · Hospital pharmacy · 2025

    Case report or series · 1 result

  5. A Case of Intussusception With Bowel Obstruction in a Gastric Roux-en-Y Patient Prescribed Semaglutide.

    Pavuluri SK · Journal of the American College of Emergency Physicians open · 2025

    Case report or series · 2 results

  6. Semaglutide-Induced Acute Pancreatitis Leading to Death After Four Years of Use.

    Dagher C · Cureus · 2024

    Case report or series · 4 results

  7. Pulmonary aspiration during upper endoscopy in a patient prescribed semaglutide.

    Dong T · Revista espanola de enfermedades digestivas · 2026

    Case report or series · 1 result

  8. GLP-1 Receptor Agonist-Associated Slimmer's Palsy: Implications for the Peripheral Nerve Surgeon.

    Dhupati P · Annals of plastic surgery · 2026

    Case report or series · 4 results

  9. Tirzepatide-Induced Liver Injury: A Rare Complication.

    Spaeth LD · AACE endocrinology and diabetes · 2026

    Case report or series · 8 results

  10. Semaglutide-associated drug-induced liver injury: a case report and review of the literature.

    Kempster I · Oxford medical case reports · 2025

    Case report or series · 2 results

  11. Semaglutide-Induced Liver Injury.

    Kalsi H · ACG case reports journal · 2025

    Case report or series · 2 results

  12. The Therapeutic Effects of Semaglutide in Congenital Linear Scleroderma.

    Chen H · Cureus · 2025

    Case report or series · 2 results

  13. Weighing the Risks: Small Bowel Obstruction Associated With Semaglutide Use in the Postoperative Abdomen.

    Nagib N · Cureus · 2025

    Case report or series · 1 result

  14. Semaglutide-Induced Small Bowel Pseudo-Obstruction and Ileitis in a Patient With Type 2 Diabetes: A Case Report.

    Javed F · Cureus · 2025

    Case report or series · 3 results

  15. Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report.

    Sekhon S · Cureus · 2025

    Case report or series · 1 result

  16. Food-induced small bowel obstruction observed in a patient with inappropriate use of semaglutide.

    Itoh Y · Diabetology international · 2024

    Case report or series · 1 result

  17. Problematic Pharmacokinetics: A Case of Recurrent Pancreatitis Post Discontinuation of a Glucagon-Like Peptide 1 Receptor Agonists.

    Morehouse ZP · Journal of pharmacy practice · 2025

    Case report or series · 2 results

  18. Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide.

    Bracha P · American journal of ophthalmology case reports · 2024

    Case report or series · 3 results

  19. Rapid Improvement in Weight, Body Composition, and Glucose Variability With Semaglutide in Type 1 Diabetes.

    Gad H · Cureus · 2024

    Case report or series · 6 results

  20. Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report.

    Denny O · Journal of pharmacy practice · 2024

    Case report or series · 1 result

  21. Semaglutide Treatment in Adult-Onset Autoimmune Diabetes: A Case Study With Long-Term Follow-Up and Periodic Evaluation of Beta-Cell Function.

    Da Porto A · Cureus · 2024

    Case report or series · 2 results

  22. An Unusual Case of an Acute Episode of Restless Leg Syndrome Following Oral Metoclopramide Therapy.

    Aljunaid MA · Cureus · 2024

    Case report or series · 1 result

  23. Efficacy of semaglutide in IgA nephropathy with obesity: a case report.

    Li H · BMC nephrology · 2026

    Case report or series · 4 results

  24. Euglycemic Ketoacidosis Following the Use of Counterfeit Semaglutide for Weight Loss.

    Sterckx M · Cureus · 2026

    Case report or series · 2 results

  25. Recurrent bilateral brachial plexus neuritis following rapid semaglutide-induced weight loss: a case report.

    Lesinszki LS · BMC neurology · 2026

    Case report or series · 2 results

  26. Unmasking an insulinoma: recurrent Hypoglycemia in a young patient following GLP-1 receptor agonist therapy -A case report.

    Baldera-Rodriguez N · Oxford medical case reports · 2026

    Case report or series · 1 result

  27. Unanticipated Residual Gastric Contents in an Appropriately Fasted Pediatric Patient on Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Case Report and Review of Perioperative Considerations.

    Lookabaugh M · Cureus · 2025

    Case report or series · 1 result

  28. A Case of Oral Semaglutide for Treatment of Hepatocyte Nuclear Factor 4A Maturity-Onset Diabetes of the Young.

    Grennan KN · AACE endocrinology and diabetes · 2026

    Case report or series · 3 results

  29. Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report.

    Parker AE · Menopause (New York, N.Y.) · 2025

    Case report or series · 3 results

  30. Inflammatory optic neuritis and scleritis following commencement of semaglutide: a case report.

    Maher CB · Journal of surgical case reports · 2025

    Case report or series · 1 result

  31. From weight loss to muscle loss: rhabdomyolysis linked to semaglutide.

    Jadvani R · Clinical kidney journal · 2025

    Case report or series · 3 results

  32. A Case of Slowly Progressive Type 1 Diabetes Mellitus (SPIDDM, Probable) Successfully Managed With Oral Semaglutide for Glycemic Control and Weight Management Accompanied by Changes in Eating Behavior.

    Hirai T · Cureus · 2025

    Case report or series · 4 results

  33. Semaglutide Overdose in a Diabetic Patient: Suicidal Behavior and Multiorgan Failure.

    Zamir D · The American journal of case reports · 2025

    Case report or series · 6 results

  34. Hypokalemia Requiring Hospitalization After Taking Semaglutide Injections.

    Grennan KN · Cureus · 2025

    Case report or series · 5 results

  35. The Impact of Semaglutide on Metabolic Syndrome: A Case Report.

    Joseph J · Cureus · 2025

    Case report or series · 5 results

  36. Weight Management in a Patient With Smith-Magenis Syndrome: The Role of GLP-1 Receptor Agonists.

    Correia JC · JCEM case reports · 2025

    Case report or series · 8 results

  37. Echoes of Dormancy: Anomic Aphasia Unveils Neurocysticercosis Reactivation in a Patient on Semaglutide.

    Osorio Borjas M · NeuroSci · 2025

    Case report or series · 1 result

  38. From Glycemic Control to Gut Telescoping: Intussusception in a Patient on a Glucagon-Like Peptide-1 Receptor Agonist.

    Thakkar B · ACG case reports journal · 2025

    Case report or series · 1 result

  39. Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report.

    Dinoi E · Frontiers in endocrinology · 2025

    Case report or series · 7 results

  40. Semaglutide and laparoscopic sleeve gastrectomy in an adolescent with congenital adrenal hyperplasia due to 21-hydroxylase: a case report.

    Vidmar AP · Journal of medical case reports · 2025

    Case report or series · 1 result

  41. Clinical Manifestations of Semaglutide Overdose: A Case Study.

    Branch MR · Journal of psychiatric practice · 2024

    Case report or series · 1 result

  42. Exocrine Pancreatic Insufficiency During the Use of Semaglutide: A Case Report.

    Agra de Melo Junior C · Cureus · 2024

    Case report or series · 5 results

  43. Appendicitis: A Hidden Danger of GLP-1 Receptor Agonists?

    Casella S · The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2024

    Case report or series · 1 result

  44. Semaglutide Initiation in a Type 2 Diabetes Mellitus, Post-Liver Transplant Patient.

    Newell BJ · The Senior care pharmacist · 2022

    Case report or series · 1 result

  45. Hemodynamic Compromise Due to Semaglutide-Associated Abdominal Distension.

    Amdahl MB · JACC. Case reports · 2026

    Case report or series · 2 results

  46. Non-Arteritic Anterior Ischaemic Optic Neuropathy Associated with Semaglutide use.

    Kearney M · Irish medical journal · 2026

    Case report or series · 2 results

  47. Glucagon-Like Peptide-1 Agonist Effects on Weight Loss and Heart Failure Hemodynamics.

    Alvarado A · JACC. Case reports · 2026

    Case report or series · 3 results

  48. Nonarteritic anterior ischemic optic neuropathy after rapid weight loss during semaglutide therapy: a case report.

    Cho CH · Korean journal of family medicine · 2026

    Case report or series · 3 results

  49. Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.

    Miura D · JCEM case reports · 2026

    Case report or series · 7 results

  50. Postmenopausal bleeding associated with semaglutide: a diagnostic challenge.

    Prasad S · JCEM case reports · 2026

    Case report or series · 6 results

How PepBank reports evidence